Day: May 13, 2022

Abeona Therapeutics Reports First Quarter 2022 Financial Results

Written by Customer Service on May 13, 2022. Posted in Earnings Releases And Operating Results.

Disposition of MPS programs to reduce operating expenses and extend projected cash runway into 2Q 2023 Focus R&D resources on EB-101 pivotal phase 3 VIITAL™ topline data expected in 3Q 2022 NEW YORK and CLEVELAND, May 13, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced financial results for the first quarter of 2022. The Company will host a conference call and webcast on Tuesday, May 17, 2022, at 8:30 a.m. ET, to discuss its financial results and business update. “During the quarter, we took significant steps to preserve our capital with the goal to fund operations over the next 12 months with existing cash resources,” said Vish Seshadri, Chief Executive Officer of Abeona. “First, we began off-loading our MPS assets to reduce cash burn. Second,...

Mullen Reports Preliminary Summary of Financial Results for Second Quarter

Written by Customer Service on May 13, 2022. Posted in Earnings Releases And Operating Results.

Mullen more than doubles reservations on the Mullen FIVE in reported quarter. The Mullen FIVE features an estimated 325-mile range and 0-60 in 3.2 seconds. Starting price at $55,000.Q/Q cash and cash equivalents rose to +$65.2M, driven primarily by the issuance of Mullen’s Series C Preferred Stock at $8.84/share Notes payable, current portion fell approximately -10.8% Q/Q to $16.9M Total assets rose approximately 138.4% to slightly over +$100M, driven mainly by financing activities Stockholders’ equity rose favorably Q/Q from a deficit of -$10.5M to a surplus of +$52.6M Subsequent to the period ended March 31, 2022, Mullen Automotive Inc. entered into an agreement with Thurner Design to develop the Mullen FIVE RS, a high-performance EV sport crossover vehicle featuring close to 1,100 HP, 0-60 mph in 1.95 seconds, and a top speed...

CytoDyn Announces the Addition of Leading Experts in Oncology, Infectious Diseases, and Neuroinflammation to its Scientific Board of Advisors; Dr. Jay Lalezari to Serve as Outside Scientific Advisor

Written by Customer Service on May 13, 2022. Posted in Public Companies.

VANCOUVER, Washington, May 13, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the addition of Dr. Paul Edison, Dr. Kabir Mody, and Dr. Otto Yang to the Company’s Scientific Board of Advisors. In addition, Dr. Jay Lalezari has agreed to serve as an outside Scientific Advisor to the Company. Dr. Paul Edison is a Senior Clinical Lecturer in Neuroscience in the Department of Brain Sciences at Imperial College London and an honorary Professor at Cardiff University. He is also the Editor-in-Chief of the journal Brain Connectivity. After his clinical training (MD), Dr. Edison received his MPhil and Ph.D. from Imperial College London, and then...

NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference

Written by Customer Service on May 13, 2022. Posted in Public Companies.

MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will be participating in the upcoming 2022 RBC Capital Markets Global Healthcare Conference. Mike Favet, CEO, is scheduled to present on Tuesday, May 17 at 9:30 a.m. Eastern Time. A live webcast of this event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com. The webcasts will be archived and available for replay for at least 90 days after the event. About NeuroPace, Inc. Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by...

CrossAmerica Partners to Present at the EIC Investor Conference on May 16

Written by Customer Service on May 13, 2022. Posted in Public Companies.

Allentown, PA, May 13, 2022 (GLOBE NEWSWIRE) — CrossAmerica Partners to Present at the EIC Investor Conference on May 16 Allentown, PA, May 13, 2022 – CrossAmerica Partners LP (NYSE: CAPL) announced today that Charles Nifong, President and CEO, and Maura Topper, CFO, will present at the Energy Infrastructure Council (EIC) Investor Conference on Monday, May 16, 2022 at 4:20 p.m. Eastern Time. The presentation will be carried live via audio webcast and will be available on the investors section of the CrossAmerica Partners website at https://caplp.gcs-web.com/webcasts-presentations. About CrossAmerica Partners LP CrossAmerica Partners LP is a leading wholesale distributor of motor fuels, convenience store operator, and owner and lessee of real estate used in the retail distribution of motor fuels. Its general partner, CrossAmerica...

Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

Written by Customer Service on May 13, 2022. Posted in Public Companies.

SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the Spring Into Action Best Ideas Virtual Investor Conference. The conference is taking place virtually from May 16 – 20, 2022. Details for access to the presentation are as follows: Spring Into Action Virtual ConferenceDate: Monday, May 16, 2022Time: 1:00 PM EDTEvent: PresentationTo register for the conference, click HERE. For additional information on Achieve visit https://ir.achievelifesciences.com About Achieve and Cytisinicline Tobacco use is currently the leading cause of preventable death that is responsible...

Alliance Creative Group (ACGX) Reports Revenue of $2,865,404 for First Quarter of 2022

Written by Customer Service on May 13, 2022. Posted in Public Companies.

Quarterly Revenues Increased $251,407 compared to 2021 for a 9.6% increase Chicago, IL , May 13, 2022 (GLOBE NEWSWIRE) — Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ending March 31, 2022. Revenues for the quarter ending March 31, 2022 (“Q1 2022”) were $2,865,404 Gross Profits for the quarter ending March 31, 2022 (“Q1 2022”) were $632,021 Net Income for the quarter ending March 31, 2022 (“Q1 2022”) were $75,529 The total assets on the Balance Sheet for the Alliance Creative Group as of 03/31/22 were $3,873,726. The total outstanding common shares as of March 31, 2022 (“Q1 2022”) were 2,149,611 with 1,423,971 of those shares in the float. The Company ended the quarter with $16,608 Cash on hand. Total Stockholder...

Oxford Lane Capital Corp. Awarded “Best Public Closed‐End CLO Fund” by Creditflux

Written by Customer Service on May 13, 2022. Posted in Public Companies.

GREENWICH, Conn., May 13, 2022 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) has been named “Best Public Closed-End CLO Fund” by Creditflux, a leading global information source covering credit funds and CLOs. The award was presented at Creditflux’s Credit Symposium and Manager Awards, which took place in London on May 10th. The annual Creditflux Manager Awards recognize leading managers and funds based purely on data over the applicable review period. The “Best Public Closed-End CLO Fund” award category measured the change in value of eligible funds between December 31, 2020 and December 31, 2021. “We are pleased to have received this recognition from Creditflux,” said...

AvePoint to Participate at Upcoming Conferences

Written by Customer Service on May 13, 2022. Posted in Public Companies.

JERSEY CITY, N.J., May 13, 2022 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the most advanced SaaS and data management platform provider, today announced that management is scheduled to present at upcoming investor conferences. Details for each event are as follows:Needham 17th Annual Technology & Media Conference, Tuesday May 17th, 2022 at 4:30 p.m. ETJefferies Software Conference, Wednesday June 1st, 2022 at 3:30 p.m. ETCowen 50th Annual Technology, Media & Telecom Conference, Thursday June 2nd, 2022 at 9:05 a.m. ETWilliam Blair 42nd Annual Growth Stock Conference, Thursday June 9th, 2022 at 11:00 a.m. ETA live and archived audio webcast of the presentations will be available on the Investor Relations website here. About AvePoint Collaborate with confidence. AvePoint provides the most advanced platform for...

Medallion Strengthens Its Up-List Plan to Facilitate Dual Listing in the U.S. and Canada

Written by Customer Service on May 13, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN – “Medallion” or the “Company”) is pleased to announce that it plans to introduce a resolution at its upcoming Annual General and Special Meeting of Shareholders (the “Shareholders’ Meeting”) to enable the Company’s common shares to continue trading on the TSX Venture Exchange (“TSX-V”) after the planned listing on the Nasdaq Capital Market (“NasdaqCM”). In its news release dated April 26, 2022, Medallion announced a new strategic plan to position the Company in the near term as a technology leader within the industries essential to the generation, storage, and efficient use of clean energy. Key parts of the plan include a strengthened executive leadership team, listing its common shares on NasdaqCM,...

Day: May 13, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals